1 / 6

Why Myriad Genetics doesn’t care about the Supreme Court’s ruling

Why Myriad Genetics doesn’t care about the Supreme Court’s ruling. [How legal woes can affect a company] Arden Perkins. Association for Molecular Pathology vs. Myriad Genetics & USPTO. Myriad was awarded patents for 2 human genes Brca1, Brca2 Indicate susceptibility to breast cancer*

yanni
Télécharger la présentation

Why Myriad Genetics doesn’t care about the Supreme Court’s ruling

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Why Myriad Genetics doesn’t care about the Supreme Court’s ruling [How legal woes can affect a company] Arden Perkins

  2. Association for Molecular Pathology vs. Myriad Genetics & USPTO • Myriad was awarded patents for 2 human genes • Brca1, Brca2 • Indicate susceptibility to breast cancer* • http://www.youtube.com/watch?v=YTVW3uZSD1E

  3. Ethical Issues • Human genes are natural products • Not patentable • Have been patented for last 20 years! • May hinder research progress • Can’t improve technology • Monopoly • Scientists & civil rights groups challenged the patents

  4. Supreme Court rules you can’t patent genes . . . But you can. • http://www.youtube.com/watch?v=CYdNFF6qORw • Strikes down gene patents • But rules that cDNA is patentable • Disconnect between scientists/legislation/politicians “Shares of Myriad Genetics (MYGN) popped nearly 11% to a four-year high in morning trading Thursday after the U.S. Supreme Court issued a mixed ruling on whether its genetic products could be patented.” –Investors.com

  5. Other Biotech companies impacted by legal issues: • Geron Inc. • Stem Cells Inc. • SAFC Must navigate a minefield of strange policies, some reasonable some not . . . If “benefits” of research are stripped from companies, will the motivation to develop them remain?

  6. Sources • http://mysticpolitics.com/insane-aclu-sues-myriad-genetics-patent-human-genes/ • http://www.businessinsider.com/supreme-court-myriad-case-2013-4 • http://www.bcaction.org/take-action/outlaw-human-gene-patents/

More Related